로딩 중…
지수 로딩 중…
퓨쳐켐
220100· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩11,190-4.03%
2026-06-19
Price Chart
퓨쳐켐-29.93%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 250.96B KRW |
| Revenue | 19.95B KRW |
| Net Income | -7.17B KRW |
| Total Assets | 69.72B KRW |
| Net Assets | 52.79B KRW |
| Employees | 87 |
| Value | |
| P/B | 4.75x |
| P/S | 12.58x |
| FCF Yield | -0.98% |
| Profitability | |
| ROE | -13.57% |
| ROA | -10.28% |
| Op. Margin | -40.43% |
| Revenue Growth | 25.29% |
| Financial Health | |
| Debt Ratio | 132.07% |
| Total Debt | 4.75B KRW |
| FCF | -2.47B KRW |
| Cash | 7.08B KRW |
| Current Ratio | 2.54x |
| Performance | |
| 1Y Return | -29.93% |
| 1M Return | -28.27% |
| From 52W High | -68.07% |
| 1Y MDD | -68.22% |
| Trading | |
| Volume | 81,918 shares |
| Foreign Own. | 7.15% |
| Per Share | |
| EPS | -484 KRW |
| BPS | 2,340 KRW |
Company Info
FutureChem, a listed corporation, was established in 2001 to manufacture and sell radiopharmaceutical precursors, transferring its listing to the KOSDAQ Market in 2016 after a KONEX Market listing in 2015. The company develops, produces, and sells new radiopharmaceutical drugs, precursors, synthetic reagents, and automated synthesis devices, holding various pipelines including Alzavue for Alzheimer's diagnosis. Its affiliates are FutureChem Healthcare, SI Healthcare, and FutureChem U.S.A. FutureChem is headquartered in Seongdong-gu, Seoul.